MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...
MediWound, an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it ...
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...
The addition of Marion General means the Lifeline of Ohio Placenta Donation Program will be available at all OhioHealth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback